Critical Areas to Review for a GLP Audit Archives

15/08/2026

The Path to Audit Success

A successful GLP audit does not happen by accident. It is the result of careful planning, thorough preparation, and a genuine commitment to GLP principles. Organizations that consistently pass GLP audits with few or no findings invest significant effort in audit preparation.

Preparing for a GLP audit can seem daunting, especially given the breadth of GLP requirements. However, by taking a systematic approach and focusing on the areas that regulators care about most, you can transform audit preparation from a stressful scramble into a manageable process.

This article provides a comprehensive guide to preparing your research laboratory for a successful GLP audit. Whether you are preparing for your first GLP audit or seeking to improve your compliance posture, these strategies will help you achieve audit success.

Understanding What Regulators Look For

Before you can prepare for a GLP audit, you must understand what regulators will be looking for. GLP inspectors evaluate compliance across multiple areas, including:

Organization and Personnel
Regulators verify that your laboratory has qualified personnel with clearly defined responsibilities. They check training records and ensure that Study Directors are properly designated.

Quality Assurance Unit
Regulators evaluate the independence and effectiveness of your QAU. They review QAU inspection records and ensure that the QAU has performed protocol and final report reviews.

Facilities and Equipment
Regulators inspect your facilities to ensure they are adequate and well-maintained. They review equipment calibration and maintenance records.

Test and Reference Items
Regulators verify that test and reference items are properly characterized, stored, and handled.

Standard Operating Procedures
Regulators review your SOPs to ensure they are comprehensive, current, and available to personnel.

Study Performance
Regulators evaluate how studies are conducted, from protocol approval to data recording. They ensure that deviations are documented and justified.

Data Integrity
Regulators scrutinize data for accuracy, completeness, and traceability. They review audit trails for electronic records.

Archives
Regulators inspect archives to ensure that study records and samples are securely stored and accessible.

Phase 1: Pre-Audit Preparation

Pre-audit preparation is the foundation of audit success. This phase involves assessing your current compliance posture, identifying gaps, and taking corrective action.

Conduct a Self-Audit
The first step in pre-audit preparation is to conduct a thorough self-audit. This involves reviewing your GLP systems against regulatory requirements and identifying areas of non-compliance. A self-audit can be conducted by your internal QAU or by external consultants.

Identify Gaps
Based on your self-audit, identify gaps in your GLP systems. These may include missing documentation, inadequate training, or deficient facilities. Prioritize gaps based on their severity and the likelihood of regulatory finding.

Develop a CAPA Plan
For each identified gap, develop a corrective and preventive action plan. The CAPA plan should include specific actions, responsible parties, timelines, and verification procedures.

Implement Corrective Actions
Implement the corrective actions identified in your CAPA plan. This may involve updating SOPs, providing additional training, or repairing equipment.

Verify Effectiveness
Once corrective actions are implemented, verify that they are effective. This may involve additional self-audits or monitoring of key performance indicators.

Phase 2: Audit Preparation Activities

With your compliance gaps addressed, you can move to more specific audit preparation activities.

Organize Your Documentation
Regulators will request documentation during the audit. Organize your documentation in advance to ensure you can provide it quickly. This includes study plans, raw data, final reports, SOPs, training records, and equipment records.

Prepare Your Facilities
Ensure that your facilities are clean, organized, and in good repair. Remove clutter and ensure that work areas are tidy. Check that signage is clear and that safety equipment is visible.

Prepare Your Personnel
Ensure that all personnel are aware that an audit is scheduled and understand their roles during the audit. Provide training on audit procedures, including how to respond to inspector questions.

Conduct Mock Audits
Mock audits are one of the most effective ways to prepare for a GLP audit. During a mock audit, an internal or external auditor conducts a simulated inspection, identifying areas for improvement and providing practice in responding to inspector questions.

Review Previous Audit Findings
If you have undergone previous GLP audits, review the findings and ensure that corrective actions are complete and effective. Regulators expect that previous findings have been addressed.

Phase 3: During the Audit

During the audit, your focus should be on cooperating with the inspector and providing complete and accurate information.

Designate an Audit Host
Designate an individual to serve as the host for the inspector. This person should be knowledgeable about your GLP systems and able to answer questions and facilitate access to personnel and records.

Respond to Inspector Questions Honestly
When the inspector asks questions, respond honestly and accurately. If you do not know the answer, say so and offer to find out. Do not speculate or provide inaccurate information.

Provide Documentation Promptly
When the inspector requests documentation, provide it promptly. If documentation is not immediately available, explain why and provide an estimated time when it will be available.

Take Notes
Take notes during the audit, especially of any observations or concerns expressed by the inspector. This will help you address findings after the audit.

Remain Professional
Throughout the audit, remain professional and courteous. Do not become defensive or argumentative, even if you disagree with the inspector’s observations.

Phase 4: Post-Audit Activities

After the audit, your focus should shift to addressing any findings and preparing for future audits.

Review Audit Findings
When you receive the audit report, review the findings carefully. Identify any areas of non-compliance and determine the root causes.

Develop CAPA Plans
For each finding, develop a CAPA plan. The plan should include specific actions, responsible parties, timelines, and verification procedures.

Implement CAPA Actions
Implement the CAPA actions identified in your plan. This may involve updating SOPs, providing additional training, or making facility improvements.

Verify Effectiveness
Once CAPA actions are implemented, verify that they are effective. This may involve additional self-audits or monitoring of key performance indicators.

Document CAPA Activities
Document all CAPA activities, including the original finding, the corrective action taken, and the verification of effectiveness. This documentation should be retained for future reference.

Learn from the Experience
Reflect on the audit experience and identify lessons learned. Consider how you can improve your compliance systems and audit preparation processes for future audits.

How GxP Cellators Can Help You Prepare for a GLP Audit

At GxP Cellators, we understand the challenges of preparing for a GLP audit. With over 500 GLP audits successfully completed, our certified GLP and IRCA auditors bring extensive experience in helping laboratories achieve audit readiness.

Our team includes professionals with RQAP-GLP and IRCA Auditor certifications, ensuring that our auditing methodologies comply with international standards. We perform GLP audits on behalf of clients and sponsors, providing objective, third-party evaluations that carry greater credibility with regulatory authorities.

Our audit preparation services include:

Gap assessments: Comprehensive reviews of your GLP systems against OECD guidelines and 21 CFR Part 58, identifying compliance gaps and providing actionable recommendations
Mock audits: Simulated inspections that provide practice in responding to inspector questions and identifying areas for improvement
Readiness audits: Comprehensive assessments of your audit readiness, identifying areas that need attention before the actual audit
Documentation review: Thorough reviews of study plans, raw data, final reports, SOPs, training records, and other documentation
CAPA support: Assistance in developing and implementing CAPA plans for identified gaps
Full-spectrum GLP study audits: Including toxicology, pharmacokinetics, bioanalytical method validation, genotoxicity, reproductive toxicology, carcinogenicity, dermal and ocular toxicology, and ecotoxicology

Why sponsors choose us: We speak both the regulatory language and the scientific language. Our findings are factual, evidenced, and actionable. As an independent third-party audit firm, we have no organizational biases or conflicts of interest. Our audit reports carry greater credibility with regulatory authorities, clients, and business partners.

Our global presence spans Saskatchewan, Calgary, Toronto, North Carolina, Indiana, and Frankfurt, enabling us to deploy auditors worldwide and understand local regulatory nuances while upholding the OECD framework.

Ready to prepare your research laboratory for a successful GLP audit? Let GxP Cellators help you achieve GLP readiness with confidence.

Reach out to us today to schedule your GLP audit.

Email:

Phone: +1 (306) 715-9460

Website: /gxp-auditing/

GxP Cellators – Your Certified GLP Audit Partners

by Vinod

15/08/2026

Documentation Is the Heart of GLP Compliance

If there is one area where laboratories consistently fall short during GLP audits, it is documentation. The FDA’s 483 observations and Warning Letters are filled with documentation-related findings, and OECD GLP inspectors similarly cite documentation deficiencies as a major area of non-compliance.

Documentation is the heart of GLP compliance. Regulatory agencies cannot inspect your laboratory operations directly. They must rely on your documentation to understand how studies were conducted, what data was generated, and whether GLP principles were followed.

This article identifies the most common documentation errors found during GLP audits and provides practical guidance on how to avoid them. By understanding these common pitfalls, you can strengthen your documentation practices and reduce your risk of audit findings.

Error 1: Corrections That Obscure Original Entries

One of the most serious documentation errors is making corrections that obscure the original entry. This includes using correction fluid or tape, overwriting, or otherwise making the original entry illegible.

Why This Is a Problem
Regulatory agencies expect that all data entries will be permanent and traceable. Obscuring the original entry makes it impossible to determine what was originally recorded, raising questions about whether data was manipulated.

How to Correct This Error
The proper correction procedure is to strike through the original entry with a single line, enter the correction, and date and initial the change. The original entry must remain legible. For electronic records, corrections must be documented through the audit trail.

How to Prevent This Error
Train all personnel on proper correction procedures. Prohibit the use of correction fluid or tape. Ensure that electronic systems have audit trails that document all changes.

Error 2: Missing Signatures and Dates

Auditors frequently find records that lack signatures or dates. This includes raw data sheets, study plans, deviation logs, and final reports.

Why This Is a Problem
Signatures and dates are essential for establishing attributability and contemporaneity. Without signatures, it is impossible to know who generated or reviewed the data. Without dates, it is impossible to know when activities occurred.

How to Correct This Error
Records that lack signatures or dates should be identified and corrected immediately. The individual who generated or reviewed the data should sign and date the record, with an explanation of why the signature was missing.

How to Prevent This Error
Implement procedures that require signatures and dates for all records. Train personnel on the importance of signing and dating records. Use checklists to ensure that all documentation is complete.

Error 3: Data Recorded on Loose Notes

Another common error is recording data on loose notes, scrap paper, or sticky notes before transcribing it to official study records.

Why This Is a Problem
Data should be recorded directly into official study records. Transcription from loose notes increases the risk of errors and omissions. Loose notes can also be lost or destroyed, resulting in data loss.

How to Correct This Error
Discourage the use of loose notes for data recording. If loose notes are used, they should be attached to the official record, with the transcribed data verified against the original notes.

How to Prevent This Error
Provide personnel with official study records for data recording. Train personnel on the importance of recording data directly into official records. Eliminate the use of loose notes for data recording.

Error 4: Failure to Document Deviations

Deviations from the approved study plan must be documented and justified. Failure to document deviations is a common finding in GLP audits.

Why This Is a Problem
Deviations from the study plan can impact the validity of study results. If deviations are not documented and justified, regulators cannot determine whether the study was conducted as planned.

How to Correct This Error
Implement a deviation management system that documents all deviations from the study plan. Deviations should include a description of the deviation, the reason for the deviation, the impact on the study, and the corrective action taken.

How to Prevent This Error
Train personnel on deviation management procedures. Encourage reporting of deviations. Implement procedures for documenting and justifying all deviations.

Error 5: Missing or Outdated SOPs

Standard Operating Procedures are essential for ensuring that activities are performed consistently and in accordance with GLP principles. Missing or outdated SOPs are a common finding in GLP audits.

Why This Is a Problem
Without SOPs, there is no assurance that activities are performed consistently. Outdated SOPs may not reflect current practices, leading to deviations.

How to Correct This Error
Identify missing or outdated SOPs and develop or update them. Ensure that SOPs are available in the laboratory and that personnel are trained on them.

How to Prevent This Error
Implement an SOP management system that includes regular review and revision. Ensure that SOPs are available in the laboratory. Train personnel on SOPs and document the training.

Error 6: Inadequate Archival Procedures

GLP requires that study plans, raw data, final reports, and samples be archived in a secure and organized manner. Inadequate archival procedures are a common finding in GLP audits.

Why This Is a Problem
Inadequate archival procedures can result in data loss, making it impossible to reconstruct the study. They can also make it difficult for inspectors to access records during an audit.

How to Correct This Error
Implement archival procedures that ensure records are stored securely, organized logically, and accessible to inspectors. Archives should have environmental controls to protect records from damage.

How to Prevent This Error
Designate an archivist responsible for archival procedures. Implement procedures for transferring records to the archive. Conduct periodic audits of the archive to ensure compliance.

How GxP Cellators Can Help You Avoid Documentation Errors

At GxP Cellators, we have conducted over 500 GLP audits and have seen every documentation error imaginable. Our certified GLP and IRCA auditors bring extensive experience in identifying documentation gaps and helping laboratories improve their documentation practices.

Our documentation audit services include:

Comprehensive documentation review covering study plans, raw data, final reports, SOPs, deviation logs, training records, and archival procedures
Gap assessments identifying documentation deficiencies and providing actionable recommendations
Sponsor-side audits of CROs with a focus on documentation practices
Full-spectrum GLP study audits including toxicology, pharmacokinetics, bioanalytical method validation, genotoxicity, reproductive toxicology, carcinogenicity, dermal and ocular toxicology, and ecotoxicology
Detailed audit reports with findings linked to specific regulations and prioritized recommendations
CAPA support and verification to ensure documentation issues are effectively addressed

Ready to strengthen your documentation practices? Let GxP Cellators help you achieve GLP compliance with confidence.

Reach out to us today to schedule your GLP audit.

Email:

Phone: +1 (306) 715-9460

Website: /gxp-auditing/

GxP Cellators – Your Certified GLP Audit Partners

by Vinod

15/08/2026

The Foundation of Regulatory Trust

Data integrity is not merely a regulatory checkbox. It is the foundation upon which regulatory trust is built. When you submit non-clinical safety data to the FDA, EMA, or other regulatory authorities, you are making a promise that the data is accurate, complete, and reliable. GLP audits are designed to verify that promise.

In recent years, data integrity has become a major focus of regulatory inspections worldwide. The FDA has issued numerous Warning Letters citing data integrity violations, and the EMA has published guidance emphasizing the importance of data integrity in GLP studies. Organizations that fail to maintain data integrity face serious consequences, including study rejection, regulatory delays, and potential legal action.

This article explores why data integrity plays a major role in GLP audits and provides practical guidance for ensuring your data meets regulatory expectations.

What Is Data Integrity in the GLP Context?

Data integrity refers to the accuracy, completeness, consistency, and reliability of data throughout its lifecycle. In the GLP context, data integrity encompasses all data generated during a non-clinical study, from raw observations to final reports.

Regulatory agencies expect that data will be:

Accurate: Free from errors and reflecting true observations
Complete: Including all data generated during the study, with no omissions
Consistent: Free from contradictions and logical inconsistencies
Reliable: Trustworthy and verifiable through audit trails
Traceable: Allowing reconstruction of the study from raw data to final report

Data integrity is not just about preventing fraud. It is about ensuring that decisions made based on your data are sound and that regulators can have confidence in your submissions.

The ALCOA+ Framework Explained

Regulatory agencies worldwide use the ALCOA+ framework to assess data integrity. ALCOA+ was originally developed by the FDA and has been adopted by the EMA, WHO, and other regulatory bodies as the standard for data integrity assessment.

The ALCOA+ principles are:

Attributable
Every data point must identify who generated it, when it was generated, and on what system. This requires user identification and authentication for electronic systems and signatures for paper records.
Legible
Data must be readable throughout its retention period. This means using permanent ink for paper records and ensuring electronic records remain accessible as technology evolves.
Contemporaneous
Data must be recorded at the time of the activity, not hours or days later. Contemporaneous recording reduces the risk of errors and omissions and provides a more accurate picture of study conduct.
Original
Data must be the first recording or a certified true copy. Original recordings provide the most reliable evidence of study conduct.
Accurate
Data must be accurate, with verified calculations and consistent units. Inaccurate data, even if unintentional, can compromise study validity.
Plus Principles
The ALCOA+ framework adds five additional principles:
Complete: All data must be included, with no omissions.
Consistent: Data must be logically consistent, with no contradictions.
Enduring: Data must be stored in durable media that will survive throughout the retention period.
Available: Data must be accessible for regulatory inspection throughout the retention period.
Traceable: Data must be traceable through all transformations and manipulations.

Common Data Integrity Violations in GLP Audits

Data integrity violations are among the most common findings in GLP audits. Some of the most frequently cited violations include:

Corrections That Obscure Original Entries
Using correction fluid, overwriting, or obscuring original entries is a serious violation. Correct procedures require striking through the error, entering the correction, and dating and initialing the change.

Missing Signatures and Dates
Auditors frequently find records that are not signed or dated. This makes it impossible to determine who generated the data and when, violating the attributability and contemporaneity principles.

Data Recorded on Loose Notes
Data should be recorded directly into official study records. Recording data on loose notes that are later transcribed increases the risk of errors and omissions.

Undocumented Deviations
Deviations from the approved study plan must be documented and justified. Undocumented deviations suggest that the study may not have been conducted as planned.

Inadequate Audit Trails
Electronic systems must maintain audit trails showing who accessed, modified, or deleted data. Inadequate audit trails make it impossible to verify data integrity.

Data Manipulation
The most serious data integrity violation is deliberate data manipulation. This can include altering data to achieve desired results, deleting data that does not support conclusions, or fabricating data entirely.

Electronic Records and Audit Trails

As laboratories increasingly adopt electronic systems, maintaining data integrity for electronic records has become a major focus of GLP audits. The FDA’s 21 CFR Part 11 establishes requirements for electronic records and electronic signatures, and OECD GLP guidance also addresses computerized systems.

Key requirements for electronic records include:

Validation
Computerized systems must be validated to ensure they perform as intended. Validation documentation must demonstrate that the system meets its specified requirements.

Audit Trails
Electronic systems must maintain audit trails showing who accessed the system, what actions were performed, and when those actions occurred. Audit trails must be enabled and cannot be disabled.

Access Controls
Access to electronic systems must be controlled through user identification and authentication. Users must have appropriate privileges based on their roles.

Backup and Recovery
Electronic records must be backed up regularly to prevent data loss. Disaster recovery procedures must be in place and tested.

Archiving
Electronic records must be archived in a format that remains readable throughout the retention period. As technology evolves, data must be migrated to new formats as needed.

How GxP Cellators Ensures Data Integrity in GLP Audits

At GxP Cellators, we understand that data integrity is the cornerstone of GLP compliance. Our auditors are trained to scrutinize data integrity at every level, from raw data generation to final report preparation.

With over 500 GLP audits successfully completed, our certified GLP and IRCA auditors bring extensive experience in identifying data integrity issues. Our team includes professionals with RQAP-GLP and IRCA Auditor certifications, ensuring that our auditing methodologies comply with international standards.

Our data integrity audit approach includes:

Raw data scrutiny: We check for the golden rules of direct, prompt, legible, dated, signed data with changes documented and no obscuring of original entries
Audit trail review: We verify that electronic systems maintain complete audit trails that cannot be disabled
Deviation analysis: We examine deviation logs to ensure all deviations are documented and justified
Data reconciliation: We trace data from raw observations through intermediate calculations to final reports, verifying accuracy and completeness
System validation review: We examine validation documentation for computerized systems
Backup and archive verification: We confirm that backup and archival procedures are in place and functioning

Our services include:

Internal gap assessments covering data integrity across all ten OECD GLP sections and corresponding subparts of 21 CFR Part 58
Sponsor-side audits of CROs with a focus on data integrity
Full-spectrum GLP study audits including toxicology, pharmacokinetics, bioanalytical method validation, genotoxicity, reproductive toxicology, carcinogenicity, dermal and ocular toxicology, and ecotoxicology
Detailed audit reports with findings linked to specific regulations and actionable recommendations
CAPA support and verification to ensure data integrity issues are effectively addressed

Ready to ensure your data integrity meets GLP standards? Let GxP Cellators help you achieve compliance with confidence.

Reach out to us today to schedule your GLP audit.

Email:

Phone: +1 (306) 715-9460

Website: /gxp-auditing/

GxP Cellators – Your Certified GLP Audit Partners

by Vinod

15/08/2026

The Scope of a GLP Audit

A Good Laboratory Practices audit is a comprehensive examination of your laboratory’s compliance with regulatory requirements. Whether conducted by the FDA, OECD member authorities, or your own internal auditors, a GLP audit covers every aspect of your non-clinical study operations.

Understanding the critical areas that auditors will scrutinize is the first step toward successful audit preparation. This article outlines the key areas every laboratory should review before a GLP audit, helping you identify potential compliance gaps and take corrective action before inspectors arrive.

Auditors examine not just your documentation but also your facilities, equipment, personnel qualifications, and quality systems. They look for evidence that GLP principles are embedded in your daily operations, not just documented in policies that are not followed. By reviewing these critical areas thoroughly, you can transform a potentially stressful audit experience into a smooth and successful inspection.

Critical Area 1: Personnel and Training

What Auditors Review

Auditors will examine the qualifications, training, and responsibilities of all personnel involved in GLP studies. This includes Study Directors, Principal Investigators, QA personnel, and technical staff.

Key Compliance Requirements

Documented job descriptions defining GLP responsibilities are essential. Complete training records for all personnel, including initial and ongoing training, must be maintained. There must be clear designation of Study Directors and Principal Investigators. Training on updated SOPs and regulatory changes must be documented and current.

Common Findings

Inadequate training records are frequently cited in FDA 483 observations. Personnel performing tasks without appropriate training is a significant compliance gap. Unclear roles and responsibilities can lead to confusion and errors. QAU personnel involved in study conduct compromises the independence required for effective quality assurance.

Review Checklist

Verify all personnel have current job descriptions. Confirm training records are complete and up-to-date. Ensure Study Directors are properly designated and qualified. Check that QAU operates with genuine independence. Review training matrices for all personnel to confirm coverage.

Critical Area 2: Quality Assurance Unit

What Auditors Review

Auditors will evaluate the independence, effectiveness, and documentation of your QAU activities. The QAU is the cornerstone of GLP compliance, and its shortcomings are a frequent source of regulatory findings.

Key Compliance Requirements

QAU independence from study conduct is non-negotiable. Study-based inspections of all studies must be conducted and documented. Facility-based inspections of laboratory operations must occur regularly. Process-based inspections of critical procedures must be performed. Protocol and final report reviews must be completed and documented. All QAU activities must be thoroughly documented.

Common Findings

QAU personnel participating in studies they inspect is a critical violation. QAU reporting to Study Directors rather than senior management compromises independence. Insufficient QAU resources leading to superficial inspections is a common issue. Missing or inadequate QAU inspection records are frequently cited.

Review Checklist

Confirm QAU independence from study conduct. Verify study-based inspection records for all studies. Review facility-based inspection schedules and reports. Check process-based inspection documentation. Ensure protocol and final report reviews are documented.

Critical Area 3: Facilities and Equipment

What Auditors Review

Your laboratory’s physical infrastructure and equipment form the foundation of GLP compliance. Auditors will examine whether facilities are adequate, equipment is properly maintained, and systems are validated.

Key Compliance Requirements

Separate laboratory space for routine and specialized procedures must be provided. Environmental controls including temperature, humidity, and ventilation must be documented and monitored. Equipment calibration must occur at defined intervals. Maintenance records for all equipment must be complete and accessible. Computerized systems must be validated with audit trails. Controlled access to electronic systems must be maintained.

Common Findings

Inadequate separation of test systems or species is a frequent violation. Missing or incomplete calibration records are commonly cited. Unvalidated computerized systems pose significant data integrity risks. Inadequate environmental monitoring can compromise study validity. Poor equipment maintenance documentation indicates systemic compliance gaps.

Review Checklist

Verify facility layout meets GLP requirements. Check equipment calibration records and certificates. Review maintenance logs for completeness. Confirm computerized systems are validated. Verify environmental monitoring records are complete and current.

Critical Area 4: Documentation and Data Integrity

What Auditors Review

Documentation is at the heart of GLP compliance. Auditors will examine study plans, raw data, final reports, SOPs, and all other documentation to ensure data integrity and traceability.

Key Compliance Requirements

Approved written study plans for all studies must be in place. Raw data must be recorded promptly and legibly. Traceable modifications to data must be documented. Accurate final reports reflecting raw data must be prepared. SOPs for all activities must be current and available. Secure archiving of plans, data, and samples must be maintained.

Common Findings

Corrections that obscure original entries are a major red flag. Missing signatures or dates indicate poor documentation practices. Failure to document deviations compromises study integrity. Data recorded on loose notes before transcription is unacceptable. Inadequate archival procedures risk data loss. Missing or outdated SOPs indicate systemic compliance issues.

Review Checklist

Verify study plans are approved and documented. Check raw data for completeness and legibility. Review data modifications for traceability. Confirm final reports accurately reflect raw data. Ensure all activities have current SOPs. Verify archival procedures are in place and functioning.

How GxP Cellators Can Help You Prepare for a GLP Audit

At GxP Cellators, we have conducted over 500 GLP audits for clients worldwide. Our certified GLP and IRCA auditors bring extensive experience in identifying compliance gaps and helping laboratories achieve GLP readiness. We offer comprehensive pre-audit reviews covering all critical areas, helping you identify and address potential findings before regulators arrive.

Our team includes professionals with RQAP-GLP and IRCA Auditor certifications, ensuring that our auditing methodologies comply with international standards for management systems and technical compliance. We perform GLP audits on behalf of clients and sponsors, ensuring compliance with OECD guidelines and 21 CFR Part 58.

Our services include:

Internal gap assessments covering all ten OECD GLP sections and corresponding subparts of 21 CFR Part 58
Sponsor-side audits of CROs including pre-study qualification, for-cause investigations, and ongoing monitoring
Full-spectrum GLP study audits covering toxicology, pharmacokinetics, bioanalytical method validation, genotoxicity, reproductive toxicology, carcinogenicity, dermal and ocular toxicology, and ecotoxicology
Detailed audit reports with major and minor non-conformities, observations, and CAPA tracking logs
CAPA support and verification to ensure corrective actions are effective

Ready to review your laboratory’s critical areas? Let GxP Cellators help you achieve GLP readiness with confidence.

Reach out to us today to schedule your GLP audit.

Email:

Phone: +1 (306) 715-9460

Website: /gxp-auditing/

GxP Cellators – Your Certified GLP Audit Partners

by Vinod

15/08/2026

The High Cost of GLP Audit Failure

In the world of non-clinical safety testing, regulatory scrutiny is intensifying. The FDA’s Bioresearch Monitoring (BIMO) program conducts routine surveillance inspections of GLP facilities, and OECD member authorities conduct similar inspections under the Mutual Acceptance of Data (MAD) framework. A single significant finding can invalidate years of research, delay product approvals, and expose your organization to regulatory action, including Warning Letters and Form 483 observations.

Yet, many laboratories treat GLP audit preparation as a frantic scramble. Pulling together documents, double-checking records, and hoping inspectors do not look too closely. This reactive approach is not only stressful but also risky. The organizations that consistently pass GLP audits with flying colors share one thing in common. They have built a culture and infrastructure where compliance is a natural state of operations, not a panic-driven exercise.

Building a laboratory that is always ready for a GLP audit requires a systematic approach that touches every facet of your operations. Here is how to achieve that state of readiness.

Why Audit Readiness Must Be a Continuous State

Regulatory inspections under 21 CFR Part 58 and the OECD Principles of GLP can occur with little notice. The FDA conducts both surveillance inspections, which are routine checks of a laboratory’s compliance, and directed inspections, which are targeted investigations of specific studies or issues. In either scenario, your laboratory’s compliance posture is evaluated in real-time.

The consequences of failure are severe. FDA Warning Letters frequently cite violations such as failure of facility management to verify test article concentration and uniformity, inadequate QAU oversight, and failure to maintain proper documentation. These findings can lead to study rejection, regulatory delays, and significant financial losses.

The solution is to build a laboratory that is compliant every day, not just when an audit is announced. This requires embedding GLP principles into your daily operations and fostering a culture where every staff member understands their compliance responsibilities.

Critical Infrastructure for GLP Compliance

Your laboratory’s physical infrastructure and equipment form the foundation of GLP compliance. Regulatory agencies expect certain standards to be met consistently.

Adequate Laboratory Space
21 CFR Part 58.49 requires that testing facilities provide separate laboratory space for routine and specialized procedures, as needed. Failure to maintain proper separation of test systems or species is a common violation that can compromise data integrity and animal welfare. Laboratories must also ensure that areas are organized to prevent cross-contamination and maintain the integrity of studies.

Calibrated and Maintained Equipment
Equipment used to generate GLP data must be calibrated at defined intervals, with maintenance records readily available. Inspectors will scrutinize calibration certificates and traceability to national standards, maintenance logs and service records, and system suitability and performance verification. Equipment that is not properly calibrated can produce inaccurate data, compromising the validity of entire studies.

Validated Computerized Systems
Electronic systems that generate, manipulate, or store GLP data must be validated, with audit trails enabled and access controls in place. A common pitfall is assuming that electronic systems are automatically compliant. They are not. Without validated audit trails, version control, and backup procedures, electronic records can be worse than paper from a data integrity perspective.

The Critical Role of Personnel and Training

Your staff are your greatest asset in maintaining GLP compliance. They are also your greatest vulnerability if not properly trained and supervised. Key requirements include up to date job descriptions defining GLP responsibilities, documented training records for all personnel, clear designation of Study Directors and Principal Investigators for multi-site studies, and continuous training on updated SOPs and regulatory requirements.

The Study Director serves as the single point of control for each study and holds ultimate responsibility for its scientific conduct and GLP data integrity. They ensure the approved study plan is followed, deviations are justified, and raw data are accurately recorded and traceable. Ultimately, they are accountable for the proper conduct of the study and for ensuring that the final report reflects the data generated.

Quality Assurance Unit Independence

The QAU is the sentinel of GLP compliance, but only if it operates with genuine independence from study conduct. QA personnel operate independently from study conduct, including from the Study Director, to verify GLP compliance through scheduled inspections, audits, and report reviews.

Regulatory agencies have identified common QAU violations that laboratories must avoid. These include QAU personnel participating in studies they inspect, QAU reporting to Study Directors rather than senior management, and insufficient QAU resources leading to superficial inspections.

An effective QAU must conduct study-based inspections, facility-based inspections, and process-based inspections to verify compliance at all levels. The QAU must also perform protocol and final report reviews, ensuring that reports accurately reflect the raw data generated during the study.

Documentation: The ALCOA+ Foundation

Data integrity is the bedrock of GLP compliance. Regulatory agencies worldwide use the ALCOA+ framework to assess data trustworthiness. Data must be attributable, meaning every data point must identify who generated it, when, and on what system. Data must be legible throughout its retention period. Data must be recorded at the time of the activity, not hours or days later. Data must be original, representing the first recording or a certified true copy. Data must be accurate with verified calculations and consistent units. Data must also be complete, consistent, enduring, and available, with no deleted data without justification, no contradictions, durable storage, and accessible archives.

Documentation failures are among the most common FDA 483 observations. Common errors include corrections that obscure original entries such as white-out or overwriting, missing signatures or dates, failure to document deviations, and data recorded on loose notes before being transcribed to official records. Every study begins with an approved written plan. All raw data must be recorded promptly and legibly, and any modification must remain traceable to demonstrate ongoing GLP compliance.

How GxP Cellators Can Help You Build an Audit-Ready Laboratory

At GxP Cellators, we understand that building an audit-ready laboratory requires more than just checking boxes. It demands a comprehensive approach to compliance that touches every aspect of your operations. With over 500 GLP audits successfully completed, our certified GLP and IRCA auditors bring global expertise to help you achieve and maintain GLP compliance.

Our team includes certified professionals with RQAP-GLP and IRCA Auditor certifications, ensuring that our auditing methodologies comply with international standards for management systems and technical compliance. We offer end-to-end GLP auditing services for non-clinical GLP studies, ensuring compliance with OECD guidelines and 21 CFR Part 58.

Our services include gap assessments, readiness audits, mock inspections, and full GLP compliance audits. We perform GLP audits on behalf of clients and sponsors, providing objective, third-party evaluations that carry greater credibility with regulatory authorities.

Our track record speaks for itself. With over 500 GLP audits completed, we have helped laboratories across the globe achieve and maintain GLP compliance. Our findings are factual, evidenced, and actionable. We do not close an audit until we see objective evidence that corrective actions work.

Are you ready to build a laboratory that is always prepared for a GLP audit? Partner with GxP Cellators to achieve GLP compliance with confidence.

Reach out to us today to schedule your GLP audit.

Email:

Phone: +1 (306) 715-9460

Website: /gxp-auditing/

GxP Cellators – Your Certified GLP Audit Partners

by Vinod

09/08/2026

Introduction: The Case for Regular GDP Audits

In the fast‑paced world of pharmaceutical distribution, it is easy to view Good Distribution Practices (GDP) audits as a one‑time event—something you do to satisfy a regulatory requirement or a customer request. This perspective is not only short‑sighted but also potentially dangerous. In reality, GDP audits should be a regular, ongoing process that drives continuous improvement and ensures long‑term compliance.

At GxP Cellators, we have performed over 300 GDP audits across the globe. Our certified GDP auditors have seen the difference that regular audits make. In this comprehensive guide, we will explore why regular GDP audits are essential for pharmaceutical distributors and how GxP Cellators can help you build a sustainable compliance programme.

Why GxP Cellators for Your GDP Auditing Needs?

GxP Cellators is a specialized international consultancy delivering expert auditing and regulatory compliance services to the pharmaceutical, biotechnology, medical device, and broader life sciences sectors. Our mission is to ensure your full alignment with global Good Practice (GxP) and ISO quality standards—safeguarding patient safety, product quality, data integrity, supply chain integrity, and regulatory reliability.

We conduct end‑to‑end, risk‑based audits designed to evaluate, strengthen, and optimize your quality and compliance systems across the life sciences value chain. Our GDP auditing services cover pharmaceutical and medical device distribution networks, including wholesalers, third‑party logistics providers (3PLs), cold chain management, storage controls, transportation validation, and traceability systems.

The Benefits of Regular GDP Audits

Regulatory Compliance

Regulatory requirements for GDP are not static; they evolve over time. Regular GDP audits ensure that you stay current with changing regulations. Our audit methodologies align with leading global regulatory authorities and international standards, including EU‑GDP Guidelines, WHO GDP Guidelines, US FDA cGMP, Health Canada GMP Requirements, and ISO 9001.

Risk Identification and Mitigation

Risks in pharmaceutical distribution are not static either. New products, new suppliers, new routes, and new personnel introduce new risks. Regular GDP audits identify these risks before they become compliance failures.

Continuous Improvement

A single GDP audit provides a snapshot of your compliance at a moment in time. Regular audits provide a longitudinal view, allowing you to track trends, measure improvement, and demonstrate a commitment to quality.

Customer Confidence

Pharmaceutical manufacturers are increasingly selective about their distribution partners. They want to work with organisations that can demonstrate a mature quality culture and a proven track record of GDP compliance. A portfolio of clean audit reports from a reputable firm like GxP Cellators can be a powerful credential.

Operational Efficiency

Regular GDP audits often uncover inefficiencies—duplication of effort, outdated procedures, and unnecessary steps. By addressing these issues, you can improve operational efficiency and reduce costs.

Brand Protection

A single GDP compliance failure can damage your brand reputation irreparably. Regular audits help you avoid the scandals, recalls, and regulatory actions that destroy trust.

How Often Should You Conduct GDP Audits?

The frequency of GDP audits depends on several factors:

Regulatory Requirements – Some regulators require annual audits. Others require audits every two or three years.
Customer Requirements – Many pharmaceutical manufacturers require annual audits of their distribution partners.
Risk Profile – High‑risk operations (e.g., cold chain, biologics, international distribution) may require more frequent audits.
Past Performance – Organisations with a history of findings may benefit from more frequent audits.

As a general rule, we recommend annual GDP audits for most pharmaceutical distributors. This frequency allows you to stay ahead of regulatory changes, identify emerging risks, and demonstrate a commitment to continuous improvement.

The GxP Cellators Approach to Regular GDP Audits

Global Reach, Regional Expertise – Our auditors have hands‑on experience across North America, Europe, Asia‑Pacific, Africa, and Latin America.
Risk‑Based, Tailored Audit Programs – We design custom audit frameworks aligned with your operational risk, regulatory exposure, and certification scope.
Integrated GxP & ISO Competence – We have the ability to assess hybrid quality systems operating under both regulatory and ISO‑based structures.
Regulatory Intelligence – We stay current with evolving regulations and best practices.
For Manufacturers – We ensure that your downstream supply chain partners meet your quality standards.
For Logistics Companies – We help you build client trust by verifying that your facilities, vehicles, and procedures comply with global GDP standards.

What a Regular GDP Audit Covers

A comprehensive GDP audit covers:

The Quality System – Risk management protocols, change control system, and CAPA process.
Infrastructure and Validation – Temperature mapping reports, calibration certificates, and facility qualification.
Operational Integrity – Supplier and customer qualification, returns, recalls, and FEFO.
Personnel Competence – Staff training and awareness.

Building a Sustainable Compliance Programme

Regular GDP audits are just one component of a sustainable compliance programme. Other key elements include:

Internal Audits – Conduct regular internal audits to identify issues before external audits.
Management Review – Regularly review quality metrics, audit findings, and customer complaints.
Training Programme – Maintain a robust training programme with initial and refresher training.
Continuous Improvement – Use audit findings to drive continuous improvement.

Conclusion: Make GDP Audits a Regular Priority

Regular GDP audits are not a luxury; they are an essential component of a sustainable compliance programme. They protect patients, preserve product quality, safeguard your business reputation, and demonstrate your commitment to excellence.

Do not wait for a regulatory inspection or a customer complaint to reveal your vulnerabilities. Contact our GDP auditing experts at today to schedule your regular GDP audit. With over 300 audits performed and a team of certified, experienced auditors, GxP Cellators is your trusted partner in pharmaceutical distribution compliance. Visit our GDP auditing services page at GxP Auditing Services to learn more.

by Vinod

09/08/2026

Introduction: Documentation Is the Backbone of GDP Compliance

In the world of pharmaceutical distribution, if it is not documented, it did not happen. This simple principle underpins every Good Distribution Practices (GDP) audit. Documentation is the evidence that your distribution operations are conducted in a controlled, compliant, and quality‑focused manner. Without proper documentation, even the best practices are invisible to an auditor.

At GxP Cellators, we have performed over 300 GDP audits across the globe. Our certified GDP auditors have reviewed thousands of documentation packages, and we have seen firsthand what works and what does not. In this comprehensive guide, we will outline the key documentation every pharmaceutical distributor should maintain for GDP audit success.

Why Documentation Matters in GDP Audits

Documentation serves multiple critical functions in a GDP audit:

Evidence of Compliance – It provides objective evidence that your operations meet GDP requirements.
Traceability – It enables you to track products from receipt to delivery, supporting recalls and investigations.
Continuous Improvement – It allows you to identify trends, analyse root causes, and implement preventive actions.
Regulatory Inspection Readiness – It demonstrates to regulators that you have a mature quality system.

Our End‑to‑End GDP Auditing Services

At GxP Cellators, we conduct end‑to‑end, risk‑based audits designed to evaluate, strengthen, and optimize your quality and compliance systems. Our GDP auditing services cover pharmaceutical and medical device distribution networks, including wholesalers, third‑party logistics providers (3PLs), cold chain management, storage controls, transportation validation, and traceability systems.

Essential Documentation Categories for GDP Audits

Quality Management System Documentation

Your Quality Management System (QMS) is the foundation of your GDP compliance. Key documents include:

Quality Manual – A high‑level document that describes your quality policy, objectives, and the structure of your QMS.
SOPs (Standard Operating Procedures) – Detailed, written instructions for all GDP‑related activities, including receiving, storage, picking, packing, shipping, temperature monitoring, deviation handling, and CAPA.
Quality Policy – A statement of your organisation’s commitment to quality and compliance.
Organisational Chart – A chart showing the structure of your quality and operational teams, including the designated Responsible Person.

Temperature Control Documentation

Temperature control is one of the most scrutinised areas in any GDP audit. Key documents include:

Temperature Mapping Reports – Reports documenting the temperature mapping of your storage areas and transport vehicles.
Calibration Certificates – Certificates for all temperature monitoring devices, demonstrating that they are calibrated at defined intervals.
Temperature Logs – Continuous temperature records for all storage areas and transport vehicles.
Alarm Test Records – Records of alarm tests, including any failures and corrective actions taken.
Contingency Plans – Plans for responding to temperature excursions, equipment failures, and power outages.

Personnel Documentation

Your staff are your most important asset in maintaining GDP compliance. Key documents include:

Training Records – Records of initial and refresher training for all GDP‑relevant personnel.
Competency Assessments – Assessments demonstrating that staff are competent to perform their duties.
Job Descriptions – Descriptions of roles and responsibilities for all GDP‑relevant positions.
Organisational Charts – Charts showing reporting lines and responsibilities.

Supplier and Customer Qualification Documentation

GDP requires that you work only with qualified suppliers and customers. Key documents include:

Supplier Qualification Files – Files for each supplier, including initial qualification, periodic re‑qualification, audit reports, and performance metrics.
Customer Qualification Records – Records demonstrating that customers are authorised to receive pharmaceutical products.
Agreements and Contracts – Written agreements with suppliers and customers that define quality expectations and responsibilities.

Operational Documentation

Your day‑to‑day operations must be documented to demonstrate compliance. Key documents include:

Receiving Records – Records of all incoming shipments, including product identification, quantity, condition, and temperature upon receipt.
Storage Records – Records of product storage locations and conditions.
Picking and Packing Records – Records of order picking and packing activities.
Shipping Records – Records of all outgoing shipments, including product identification, quantity, destination, and temperature during transit.
Deviation Reports – Reports of any deviations from approved procedures or specifications.
CAPA Records – Records of corrective and preventive actions, including root‑cause analysis, action plans, and effectiveness verification.

Transportation Documentation

Transportation is a critical link in the distribution chain. Key documents include:

Shipping Validation Reports – Reports validating that shipping containers maintain product temperatures under worst‑case conditions.
Vehicle Qualification Records – Records demonstrating that transport vehicles are qualified for GDP‑compliant transport.
Driver Training Records – Records of training for drivers on GDP requirements and procedures.
Temperature Records During Transit – Continuous temperature records for all shipments.

Recall and Returns Documentation

GDP requires that you have robust procedures for recalls and returns. Key documents include:

Recall Procedure – A written procedure for conducting recalls, including roles and responsibilities.
Mock Recall Records – Records of mock recall exercises, demonstrating that your recall procedure is effective.
Returns Management Procedure – A written procedure for handling returns, including quarantine, inspection, and disposition.
Returns Records – Records of all returned products, including reason for return, condition, and disposition.

The GxP Cellators Advantage

At GxP Cellators, we understand that documentation can be overwhelming. That is why we offer comprehensive GDP auditing services that include a thorough review of your documentation systems.

Our certified GDP auditors have hands‑on experience across North America, Europe, Asia‑Pacific, Africa, and Latin America. We design risk‑based, tailored audit programs aligned with your operational risk, regulatory exposure, and certification scope.

For Manufacturers – We ensure that your downstream supply chain partners meet your quality standards.

For Logistics Companies – We help you build client trust by verifying that your facilities, vehicles, and procedures comply with global GDP standards.

Conclusion: Get Your Documentation Audit‑Ready

Documentation is the backbone of GDP compliance. By maintaining complete, accurate, and up‑to‑date documentation, you demonstrate to auditors that your distribution operations are controlled, compliant, and quality‑focused.

Do not wait until the last minute to review your documentation. Contact our GDP auditing experts at today to schedule a comprehensive documentation review. With over 300 audits performed and a team of certified, experienced auditors, GxP Cellators is your trusted partner in GDP audit preparation. Visit our GDP auditing services page at GxP Auditing Services to learn more.

by Vinod

09/08/2026

Introduction: The Importance of Being Audit‑Ready

A Good Distribution Practices (GDP) audit is one of the most significant events in a pharmaceutical distributor’s calendar. The outcome can determine whether you retain your operating license, win new business, or face regulatory sanctions. Yet, surprisingly, many organisations treat audit preparation as a last‑minute scramble.

The secret to a successful GDP audit is preparation. Not just a week before, but a continuous, systematic effort that builds compliance into the fabric of your daily operations. In this comprehensive guide, we will walk you through a step‑by‑step preparation process that has been refined over 300+ GDP audits performed by our team at GxP Cellators.

Why Choose GxP Cellators for Your GDP Audit Preparation?

At GxP Cellators, we are a specialized international consultancy delivering expert auditing and regulatory compliance services to the pharmaceutical, biotechnology, medical device, and broader life sciences sectors. Our certified GDP auditors have hands‑on experience across North America, Europe, Asia‑Pacific, Africa, and Latin America.

We offer comprehensive GDP auditing services that include pre‑audit gap assessments, on‑site inspections, detailed audit reports, and post‑audit CAPA support. Our risk‑based, tailored audit programs are designed to evaluate, strengthen, and optimize your quality and compliance systems.

Step 1: Understand the Scope and Objectives of the Audit

Before you can prepare, you need to know exactly what the audit will cover. GDP audits are not generic; they are tailored to the specific products, markets, and regulatory jurisdictions of your distributor network.

Common elements include:

Storage and Warehousing – Condition of premises, temperature control, housekeeping, pest control, and security.=
Transportation – Vehicle qualifications, temperature monitoring during transit, driver training, and shipping documentation.
Quality Management System – Deviation handling, CAPA processes, change control, and management review.
Personnel – Training records, competency assessments, and organisational structure.
Documentation – Standard operating procedures (SOPs), batch records, and traceability logs.

If you are engaging GxP Cellators, we will work with you to define the scope in advance, ensuring that there are no surprises on the day of the audit.

Step 2: Conduct a Self‑Audit (Gap Assessment)

A self‑audit or gap assessment is the single most effective preparation tool available. It allows you to identify weaknesses before the external auditor does.

During the self‑audit, use the same criteria that the external auditor will use. Walk through your entire facility, observe operations, review documentation, and interview staff. Pay special attention to the high‑risk areas that commonly generate findings.

At GxP Cellators, we offer pre‑audit gap assessments as part of our GDP auditing services. Our certified auditors conduct a mock audit that mirrors the real thing, providing you with a detailed gap report and a prioritised action plan.

Step 3: Review and Update Standard Operating Procedures (SOPs)

Your SOPs are the backbone of your GDP compliance. During an audit, the auditor will compare your actual practices against your written procedures. If there is a mismatch, it is a finding.

Review all GDP‑related SOPs well in advance. Ensure they are current, accurate, and reflect your actual operations. Pay special attention to procedures for temperature monitoring, deviation handling, CAPA, supplier qualification, training, recalls, and returns.

Step 4: Verify Your Temperature Control Systems

Temperature control is one of the most scrutinised areas in any GDP audit. Verify that your temperature mapping studies are up‑to‑date and that all monitoring devices are calibrated. Test your alarm systems and ensure that there are clear procedures for responding to temperature excursions.

Step 5: Review Training Records and Conduct Refresher Training

Auditors will examine training records for all personnel involved in distribution. Ensure that records are complete and that refresher training has been conducted at the required intervals. Consider conducting additional training sessions to address any identified gaps.

Step 6: Prepare Your Documentation

Auditors will request a wide range of documents. Prepare a documentation package that includes:

Quality Manual and GDP‑related SOPs
Temperature mapping reports and calibration certificates
Training records and competency assessments
Supplier qualification files
Deviation and CAPA records
Recall and returns procedures
Shipping validation reports

Step 7: Conduct a Mock Audit

A mock audit is the best way to test your readiness. Conducted by an independent party, it simulates the real audit and identifies any remaining gaps.

At GxP Cellators, our certified GDP auditors can conduct a comprehensive mock audit that mirrors the real thing. We provide a detailed gap report and a prioritised action plan, so you can address issues before the official audit arrives.

Step 8: Prepare Your Staff

Your staff are your first line of defence during an audit. Ensure that all personnel understand their roles and responsibilities. Conduct interview preparation sessions to help staff feel confident and articulate when speaking with auditors.

The GxP Cellators Advantage

Global Reach, Regional Expertise – Our auditors have hands‑on experience across North America, Europe, Asia‑Pacific, Africa, and Latin America.
Risk‑Based, Tailored Audit Programs – We design custom audit frameworks aligned with your operational risk, regulatory exposure, and certification scope.
Integrated GxP & ISO Competence – We have the ability to assess hybrid quality systems operating under both regulatory and ISO‑based structures.
Regulatory Intelligence – We stay current with evolving regulations and best practices.
For Manufacturers – We ensure that your downstream supply chain partners meet your quality standards.
For Logistics Companies – We help you build client trust by verifying that your facilities, vehicles, and procedures comply with global GDP standards.

Conclusion: Be Audit‑Ready with GxP Cellators

A GDP audit is a significant event, but with the right preparation, it can be a smooth and successful experience. By following this step‑by‑step guide and partnering with GxP Cellators, you can approach your audit with confidence.

Do not wait until the last minute. Contact our GDP auditing experts at today to schedule your pre‑audit gap assessment. With over 300 audits performed and a team of certified, experienced auditors, GxP Cellators is your trusted partner in GDP audit preparation. Visit our GDP auditing services page at GxP Auditing Services to learn more.

by Vinod

09/08/2026

Understanding the Recurring Patterns in GDP Audits

Even well‑managed pharmaceutical distributors can be surprised by recurring findings during a GDP audit. These common observations are not random—they are patterns that emerge from overlooked details, outdated procedures, or insufficient training. The good news is that each of these findings is preventable with the right proactive measures.

Over the course of our 300+ GDP audits performed at GxP Cellators, our certified auditors have consistently identified a core set of issues that appear across different regions, company sizes, and product types. By understanding these patterns, you can take targeted action to avoid them and ensure a smooth, successful audit outcome.

Why Partner with GxP Cellators for GDP Audit Preparation?

At GxP Cellators, we are a specialized international consultancy delivering expert auditing and regulatory compliance services to the global life sciences sector. Our GDP auditing services are designed to help you identify and rectify these issues before they become major compliance headaches.

We offer pre‑audit gap assessments that specifically target these high‑risk areas. We work with you to review your temperature monitoring, deviation management, supplier qualification, training records, housekeeping, transportation validation, and recall procedures before the official audit arrives. We provide a detailed gap analysis report with prioritised recommendations, so you can fix issues proactively.

Below are the seven most frequent GDP audit findings, along with a deep dive into why they happen and, most importantly, how you can prevent them.

Finding 1: Inadequate Temperature Monitoring and Mapping

What Auditors See

During our audits, we frequently encounter storage areas and transport vehicles that lack up‑to‑date temperature mapping studies. Temperature monitoring devices are often not calibrated at the required frequency. Alarm systems are installed but rarely tested.

Why It Happens

Many managers believe that once a facility is validated, it stays validated forever. They underestimate how physical changes, seasonal variations, and equipment aging can alter temperature profiles.

How to Prevent It

Schedule regular temperature mapping at least annually. Calibrate all monitoring devices at defined intervals. Test alarm systems monthly. Document all temperature excursions and implement CAPAs to prevent recurrence.

Finding 2: Poor Documentation of Deviations and CAPAs

What Auditors See

Deviation records are often incomplete or superficial. CAPA plans are written but not tracked to closure. There is no formal system for trending deviations.

Why It Happens

Staff responsible for investigations may lack training in root‑cause analysis techniques. Quality departments are often understaffed.

How to Prevent It

Implement a formal deviation management procedure that requires a structured root‑cause analysis. Use tools like the 5‑Whys or Fishbone diagrams. Assign clear ownership for each CAPA. Verify the effectiveness of CAPAs through follow‑up audits.

Finding 3: Supplier Qualification Gaps

What Auditors See

Distributors lack up‑to‑date qualification files for their suppliers. Audits of critical suppliers are overdue. There is no risk‑based approach to supplier qualification.

Why It Happens

Supplier qualification is seen as a one‑time activity rather than an ongoing process.

How to Prevent It

Establish a supplier qualification programme with initial qualification, periodic re‑qualification, and a risk‑based approach. Maintain a central repository for all supplier documentation.

Finding 4: Insufficient Training Records

What Auditors See

Training records are incomplete. Refresher training is not scheduled. New hires are allowed to handle products before completing training.

Why It Happens

Training is treated as an administrative chore rather than a critical quality activity.

How to Prevent It

Develop a comprehensive training matrix for every job role. Use a learning management system (LMS) to track completions. Include practical, hands‑on training sessions.

Finding 5: Poor Warehouse Housekeeping and Pest Control

What Auditors See

Cluttered warehouses with pallets stacked too close to walls. Evidence of pest activity. Cleaning schedules are not adhered to.

Why It Happens

Housekeeping is deprioritised in busy warehouses.

How to Prevent It

Develop a written housekeeping procedure. Implement a pest control programme with physical barriers and monitoring devices. Train all staff on cleanliness.

Finding 6: Transportation Validation Gaps

What Auditors See

Distributors have not adequately validated their transportation processes. Temperature records are missing for entire legs of the journey.

Why It Happens

Transportation validation is expensive and logistically challenging.

How to Prevent It

Implement a comprehensive transportation validation protocol covering all routes, seasons, and modes of transport. Use temperature data loggers on every shipment during validation trials.

Finding 7: Incomplete Recall and Returns Procedures

What Auditors See

Recall procedures are documented but never tested. Staff are unclear about their roles. Returns handling is problematic.

Why It Happens

Recalls are rare events, so organisations become complacent.

How to Prevent It

Develop a written recall procedure. Conduct mock recall exercises at least annually. Implement a formal returns management process.

How GxP Cellators Helps You Prevent These Common Findings

At GxP Cellators, our certified GDP auditors have seen these seven findings more times than we can count. That is why we offer pre‑audit gap assessments that specifically target these high‑risk areas.

We also offer post‑audit CAPA support to help you close findings efficiently and effectively. Our approach is collaborative, not adversarial. We want you to succeed, because your success is our success. With over 300 GDP audits under our belt, we have developed a keen eye for these common patterns, and we know exactly what regulators are looking for.

Our GDP auditing services cover the entire journey: from pre‑audit gap analysis and on‑site inspection to detailed reports and CAPA support. We work with clients in North America, Europe, Asia‑Pacific, Africa, and Latin America, ensuring that your distribution practices meet both local and global standards.

Conclusion: Prevention Is Better Than Correction

The seven findings discussed above are not inevitable. With the right systems, training, and oversight, they can be prevented entirely. Regular internal audits, thorough gap assessments, and a commitment to continuous improvement are the keys to staying ahead of these common issues.

If you are preparing for a GDP audit and want to ensure that these findings do not appear on your report, reach out to us at . Our team at GxP Cellators is ready to help you identify vulnerabilities and implement robust preventive measures. Visit our GDP auditing services page at GxP Auditing Services to learn more.

by Vinod

09/08/2026

Introduction: The Fragile Journey of a Medicine

Every pharmaceutical product embarks on an incredible journey. It begins in a controlled manufacturing environment, passes through multiple warehouses, crosses borders, changes hands between logistics providers, and finally reaches a pharmacy, hospital, or patient’s doorstep. At each step, the product is vulnerable to temperature swings, physical damage, delays, and even deliberate counterfeiting. A single mistake can render a life‑saving drug ineffective or, worse, dangerous.

This is where Good Distribution Practices (GDP) audits step in as the silent guardians of the pharmaceutical supply chain. A GDP audit is not merely a compliance exercise demanded by regulators; it is a systematic, risk‑based examination that uncovers weaknesses, verifies controls, and ensures that every link in the distribution chain operates with the highest standards of quality and safety. For distributors, manufacturers, and patients alike, these audits are the bedrock of trust in the pharmaceutical ecosystem.

GxP Cellators: Your Trusted Partner in GDP Auditing

At GxP Cellators, we are a specialized international consultancy delivering expert auditing and regulatory compliance services to the pharmaceutical, biotechnology, medical device, and broader life sciences sectors. Our mission is to ensure your full alignment with global Good Practice (GxP) and ISO quality standards—safeguarding patient safety, product quality, data integrity, supply chain integrity, and regulatory reliability.

We have performed over 300 GDP audits globally, covering wholesalers, third‑party logistics providers (3PLs), cold chain specialists, and hospital distribution networks. Our certified GDP auditors bring decades of hands‑on experience from both industry and regulatory agencies. We do not simply tick boxes; we dig deep to uncover latent risks that could compromise product quality.

What Exactly Is a GDP Audit?

Before we explore how a GDP audit protects the supply chain, it is essential to understand what such an audit entails. GDP refers to the minimum standards that wholesalers and distributors must meet to ensure that the quality and integrity of pharmaceutical products are maintained throughout the distribution process. These guidelines are published by international bodies such as the World Health Organization (WHO) , the European Union (EU) , and the Pharmaceutical Inspection Co‑operation Scheme (PIC/S) . They are not optional recommendations; they are mandatory requirements in most regulated markets.

A GDP audit is an independent, documented evaluation of a distributor’s operations against these established standards. It covers every facet of distribution: procurement, receipt, storage, transportation, and delivery. During a GDP audit, qualified auditors examine physical facilities, equipment, temperature monitoring systems, personnel training, documentation practices, and quality management systems.

Our End‑to‑End GDP Auditing Services

At GxP Cellators, we conduct end‑to‑end, risk‑based audits designed to evaluate, strengthen, and optimize your quality and compliance systems across the life sciences value chain. Our GDP auditing services cover:

Pharmaceutical and medical device distribution networks – We audit wholesalers, third‑party logistics providers (3PLs), cold chain management, storage controls, transportation validation, and traceability systems.

Comprehensive audit scope – Our audits cover the Quality System (risk management, change control, CAPA processes), infrastructure and validation (temperature mapping, calibration certificates, facility qualification), operational integrity (supplier qualification, returns, recalls, FEFO), and personnel competence (training and awareness).

Global regulatory alignment – Our audit methodologies align with leading global regulatory authorities and international standards, including EU‑GDP Guidelines, WHO GDP Guidelines, US FDA cGMP (21 CFR Parts 210 & 211), Health Canada GMP Requirements, and ISO 9001.

The Multilayered Protection Afforded by GDP Audits

Temperature Control and Cold Chain Integrity

Perhaps the most visible risk in pharmaceutical distribution is temperature deviation. Many drugs—including vaccines, insulin, biologics, and certain antibiotics—require strict storage conditions. A GDP audit scrutinises every aspect of temperature control. Auditors verify that storage areas have been properly mapped, that temperature monitoring devices are calibrated, and that alarm systems are tested regularly. They examine contingency plans and review shipping validation protocols.

Supply Chain Security and Counterfeit Prevention

Counterfeit pharmaceutical products are a global scourge. A GDP audit verifies that your distributor network operates only with authorised trading partners who hold valid licensure. Auditors examine supplier qualification files, review product tracing systems including serialisation and aggregation, and test electronic traceability systems. They assess how the distributor handles suspected counterfeit products and review physical security measures.

Quality Management System Effectiveness

During a GDP audit, auditors evaluate whether your Quality Management System (QMS) is truly fit for purpose. They review how deviations are documented and investigated, examine CAPA (Corrective and Preventive Action) processes, and scrutinise change control and management review procedures.

Personnel Competency and Training

A GDP audit inspects training records with a fine‑tooth comb. Auditors verify that all personnel have received initial training on GDP principles, that refresher training is provided at defined intervals, and that competency assessments are conducted. Auditors often conduct on‑the‑spot interviews to gauge practical knowledge.

The GxP Cellators Advantage

Navigating international GDP standards requires specialized expertise. GxP Cellators provides this expertise. Here is what sets us apart:

Global Reach, Regional Expertise – Our auditors have hands‑on experience across North America, Europe, Asia‑Pacific, Africa, and Latin America.
Risk‑Based, Tailored Audit Programs – We design custom audit frameworks aligned with your operational risk, regulatory exposure, and certification scope.
Integrated GxP & ISO Competence – We have the ability to assess hybrid quality systems operating under both regulatory and ISO‑based structures.
Regulatory Intelligence – We stay current with evolving regulations and best practices.
For Manufacturers – We ensure that your downstream supply chain partners meet your quality standards. We help you qualify third‑party logistics (3PL) providers, ensuring your products remain compliant from the moment they leave your dock.
For Logistics Companies – We help you build client trust. Our audits verify that your facilities, vehicles, and procedures comply with global GDP standards, supporting operational excellence and attracting leading pharmaceutical clients.

The Business Case for Regular GDP Audits

Some distributors view GDP audits as a cost burden. In reality, regular GDP audits are an investment that yields significant returns. They reduce the risk of product recalls, improve operational efficiency, and enhance customer confidence. A strong GDP compliance record can be a competitive differentiator in a crowded market.

Conclusion: A GDP Audit Is Your Supply Chain’s Best Defence

The pharmaceutical supply chain is under constant pressure. In this environment, a GDP audit is not a luxury or a burden; it is an essential defence mechanism that protects patients, preserves product quality, and safeguards business reputation.

Do not wait for a regulatory inspection or a product recall to reveal your vulnerabilities. Contact our GDP auditing experts at today to schedule your comprehensive GDP audit. With over 300 audits performed and a team of certified, experienced auditors, GxP Cellators is your trusted partner in pharmaceutical supply chain protection. Visit our GDP auditing services page at GxP Cellators to learn more.

Older Posts